title: Successful treatment of stiff person syndrome with sequential use of tacrolimus.
authors.forename: Shunya
authors.initials: S
authors.lastname: Nakane
authors.forename: Koji
authors.initials: K
authors.lastname: Fujita
authors.forename: Yoshiko
authors.initials: Y
authors.lastname: Shibuta
authors.forename: Naoko
authors.initials: N
authors.lastname: Matsui
authors.forename: Masafumi
authors.initials: M
authors.lastname: Harada
authors.forename: Ryo
authors.initials: R
authors.lastname: Urushihara
authors.forename: Yoshihiko
authors.initials: Y
authors.lastname: Nishida
authors.forename: Yuishin
authors.initials: Y
authors.lastname: Izumi
authors.forename: Ryuji
authors.initials: R
authors.lastname: Kaji
mesh_terms: D000368:Aged; D001323:Autoantibodies / Q000097:blood; D001921:Brain / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D019054:Evoked Potentials, Motor / Q000187:drug effects; D005260:Female; D005500:Follow-Up Studies; D005968:Glutamate Decarboxylase / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008875:Middle Aged; D009044:Motor Cortex / Q000187:drug effects / Q000503:physiopathology; D009460:Neurologic Examination / Q000187:drug effects; D016750:Stiff-Person Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D016559:Tacrolimus / Q000008:administration & dosage*; D050781:Transcranial Magnetic Stimulation; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
chemical_list: D001323:Autoantibodies; D007166:Immunosuppressive Agents; D005680:gamma-Aminobutyric Acid; D005968:Glutamate Decarboxylase; D016559:Tacrolimus
keywords: NEUROIMMUNOLOGY; NEUROMUSCULAR